PFE - PFIZER INC
26.62
0.040 0.150%
Share volume: 30,790,196
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$26.58
0.04
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-29-2024 | 12-31-2024 | 03-30-2025 | 06-29-2025 | 09-28-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-05-2024 | 11-04-2024 | 02-27-2025 | 05-05-2025 | 08-05-2025 | 11-04-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 221.095 B | 216.193 B | 219.476 B | 213.396 B | 208.028 B | 206.095 B | 208.731 B | 208.160 B | |
| Current Assets | 42.414 B | 37.825 B | 43.223 B | 50.358 B | 45.861 B | 43.703 B | 46.924 B | 42.898 B | |
| Inventories | 10.892 B | 11.447 B | 11.721 B | 10.851 B | 10.852 B | 11.669 B | 11.468 B | 10.654 B | |
| Other Current Assets | 8.605 B | 4.190 B | 3.855 B | 4.253 B | 2.947 B | 2.690 B | 2.358 B | 2.808 B | |
| Short Term Investments | 8.605 B | 6.048 B | 8.860 B | 19.434 B | 15.887 B | 11.611 B | 13.641 B | 12.454 B | |
| Total Receivables | 10.989 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 11.928 B | 1.052 B | 1.092 B | 1.043 B | 1.430 B | 1.638 B | 1.343 B | 1.142 B | |
| Total Non-current Assets | 178.681 B | 11.148 B | 10.762 B | 2.227 B | 2.013 B | 2.120 B | 2.137 B | 1.621 B | |
| Property Plant Equipment | 18.803 B | 18.957 B | 18.541 B | 18.393 B | 18.347 B | 18.776 B | 18.880 B | 19.317 B | |
| Other Assets | 16.139 B | 159.410 B | 157.713 B | 144.644 B | 143.820 B | 143.617 B | 142.927 B | 145.946 B | |
| Intangible Assets | 62.829 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 69.297 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 221.095 B | 216.193 B | 219.476 B | 213.396 B | 208.028 B | 206.095 B | 208.731 B | 208.160 B | |
| Total liabilities | 128.812 B | 128.218 B | 126.918 B | 124.899 B | 117.391 B | 117.083 B | 115.635 B | 121.385 B | |
| Total current liabilities | 40.497 B | 43.819 B | 43.211 B | 42.995 B | 36.452 B | 37.726 B | 36.596 B | 36.984 B | |
| Accounts Payable | 5.591 B | 5.106 B | 5.314 B | 5.633 B | 5.240 B | 5.166 B | 5.024 B | 5.240 B | |
| Other liabilities | 25.801 B | 16.095 B | 15.569 B | 14.150 B | 13.297 B | 13.931 B | 13.605 B | 14.725 B | |
| Current long term debt | 8.232 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 61.307 B | 57.506 B | 58.002 B | 57.405 B | 57.639 B | 57.502 B | 57.409 B | 61.641 B | |
| Other liabilities | 25.801 B | 16.095 B | 15.569 B | 14.150 B | 13.297 B | 13.931 B | 13.605 B | 14.725 B | |
| Minority interest | 276.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 92.282 B | 87.700 B | 92.285 B | 88.203 B | 90.338 B | 88.695 B | 92.802 B | 86.476 B | |
| Common stock | 5.657 B | 93.677 B | 93.957 B | 94.083 B | 94.337 B | 94.534 B | 94.729 B | 94.950 B | |
| Retained earnings | 121.318 B | 116.596 B | 121.059 B | 116.725 B | 119.590 B | 117.609 B | 121.150 B | 114.610 B |